Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial

Bruno François, Pierre‐François Laterre, Marc Derive et al.|BMJ Open|2021

Cited by 20